secwatch.observer — SEC 8-K summary
======================================

Issuer:     VivoSim Labs, INC. (VIVS)
CIK:        0001497253
Form:       8-K
Filed at:   2026-07-24T20:07:32+00:00
Accession:  0001213900-26-081377
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

VivoSim Labs receives Nasdaq delisting notice; subsequent transactions restore equity above $2.5M
--------------------------------------------------------------------------------

- Received Nasdaq delisting notice on July 20, 2026 for failing to maintain $2.5M minimum stockholders' equity; equity was $(1,099,000) as of March 31, 2026.
- Company has 45 days (until Sept 3, 2026) to submit a compliance plan; Nasdaq may grant up to 180-day extension.
- Subsequent transactions boosted equity above $2.5M: $5M milestone from Eli Lilly, $4M private placement, and $5.1M from warrant exercises.
- As of filing, stockholders' equity exceeds $2.5M and shares outstanding are 12,057,789.
- No immediate effect on listing; stock continues trading under VIVS on Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1497253/000121390026081377/0001213900-26-081377-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1497253/000121390026081377/ea0299224-8k_vivo.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-081377

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer